The greatest harm of diabetes is various acute and chronic complications, especially diabetic retinopathy(DR), leading to extremely high rates of disability and blindness. Early screening, early diagnosis, and early treatment are the keys to maintaining vision in patients with DR. However, compared with the high prevalence of diabetes in China, the DR screening ability is relatively inadequate. To change this situation, deep learning(DL), a form of artificial intelligence (AI), might be a potential effective method to solve this dilemma.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Meet the diagnostic criteria for type 2 diabetes according to the World Health Organization (WHO) in 1999; Type 1 diabetes, single gene mutation diabetes, secondary diabetes caused by pancreatic damage, Cushing's syndrome, thyroid dysfunction, or acromegaly;
* Subjects from other medical institutes are diabetes, non-diabetic patients and healthy participants who are invited to participate in the study.
Exclusion Criteria:
* Those who have a history of drug abuse;
* Sexually transmitted diseases such as AIDS and syphilis, and infectious diseases such as viral hepatitis and tuberculosis which are at active phase;
* Any condition that the investigator think that the subject is not suitable for participating in the study.
For detailed In-/Ex-clusion criteria please see the study protocol.
Primary outcome measure(s)
Diabetic retinopathy — through study completion, up to 20 years diabetic retinopathy
Referable diabetic retinopathy — through study completion, up to 20 years Referable diabetic retinopathy
Vision threatening diabetic retinopathy — through study completion, up to 20 years Vision threatening diabetic retinopathy
Diabetic macular edema — through study completion, up to 20 years Diabetic macular edema
Trial sites (2)
Facility
City
Region
Status
Ruijin hospital, Shanghai Jiao-Tong University School of Medicine
Shanghai
Shanghai Municipality
Recruiting
Shanghai Jiao-Tong University School of Medicine
Shanghai
China
Recruiting
More Shanghai Jiao Tong University School of Medicine trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.